Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Promino Nutritional Sciences Inc C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to assist in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Rejuvenate helps boost energy and strengthen the metabolism and immune system. The Company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury.


CSE:MUSL - Post by User

Post by waves1on May 13, 2022 3:13pm
66 Views
Post# 34682602

$ELMT up 6% after an 18% jump yesterday!

$ELMT up 6% after an 18% jump yesterday!
Another day in the green for Element Nutritional Sciences ($ELMT.c $ELNSF), up over 6% so far at $0.24!
 
Seems $ELMT is experiencing some upwards movement following the $3.5M financing and significant FY 2021 financial results. Given $ELMT has exclusive rights to patented formulations targeting and preventing muscle loss due to aging, is sold in 16,000+ stores, is backed by 25 peer-reviewed clinical studies, and $20M in investments, $ELMT is in a position for this growth to continue in the long term IMO.
<< Previous
Bullboard Posts
Next >>